Excelsior Medical Co., Ltd. (TPE:4104)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
71.00
0.00 (0.00%)
Aug 28, 2026, 1:30 PM CST

Excelsior Medical Financials Overview

Millions TWD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
9,2018,7898,5398,2337,1876,573
Revenue Growth
6.33%2.94%3.71%14.56%9.34%-1.53%
Gross Profit
1,9681,8741,7811,6701,5141,374
Operating Income
719.98727.54753.32702.88606.61595.03
Net Income
894.47805.86771.26746.61667.45607.15
Earnings Per Share
4.874.684.484.333.873.52
EPS Growth
3.55%4.46%3.38%11.88%10.16%5.78%

Revenue by Segment

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Yaoya Segment
1,3951,3871,5731,5941,2921,028
Excelsior Medical Department
5,6575,4295,2915,2474,6544,373
Arich Enterprise Department
1,5621,5471,2981,1401,018945.66
Other Department
819.23634.26546.46394.17305.51323.59
Adjustment and Elimination
-307.87-208.21-169.37-141.21-82.81-97.47
Total
9,2018,7898,5398,2337,1876,573

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
4,5283,5345,0483,4063,2293,772
Total Debt
2,4102,1541,4261,442808.58761.99
Net Cash (Debt)
2,1181,3813,6221,9642,4203,010
Net Cash Growth
73.22%-61.88%84.42%-18.85%-19.59%5.90%
Net Cash Per Share
11.548.0121.0311.4014.0417.45

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
532.62-1,3642,471107.1637.13945.05
Capital Expenditures
-96.56-77.79-114.87-126.37-171.6-164.69
Free Cash Flow
436.07-1,4412,357-19.27465.53780.36
Free Cash Flow Growth
-27.46%----40.34%-6.96%

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
21.39%21.33%20.86%20.28%21.07%20.90%
Operating Margin
7.83%8.28%8.82%8.54%8.44%9.05%
Pretax Margin
13.74%13.45%13.75%13.90%13.41%13.29%
Profit Margin
9.72%9.17%9.03%9.07%9.29%9.24%
FCF Margin
4.74%-16.40%27.60%-0.23%6.48%11.87%

Dividends

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Dividend Per Share
4.3004.3003.8003.4473.1532.879
Dividend Per Share Growth
18.82%13.16%10.25%9.31%9.50%-0.00%
Dividend Yield
6.02%5.67%5.22%5.04%6.56%7.80%

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
14.5717.3718.2218.4315.0113.39
Forward PE
-17.0317.8115.7115.7111.84
P/FCF Ratio
30.67-5.96-21.5210.42
PS Ratio
1.451.591.651.671.391.24